RECRUITING

PET/MRI in the Diagnosis of Chronic Pain

Description

Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using \[18F\]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of \[18F\]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.

Study Overview

Study Details

Study overview

Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using \[18F\]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of \[18F\]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.

Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain

PET/MRI in the Diagnosis of Chronic Pain

Condition
Neuropathic Pain
Intervention / Treatment

-

Contacts and Locations

Stanford

Stanford University, Stanford, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. At least 18 years old.
  • 2. Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
  • 1. At least 18 years old.
  • 2. Chronic pain (nociceptive, neuropathic or mixed pain) lasting greater than 2 months.
  • 3. Pain level of at least 4/10 on a 0-10 Comparative Pain Scale.
  • 4. Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
  • 1. Pain
  • 2. Pain Medication
  • 3. MRI incompatible
  • 4. Pregnant or nursing
  • 5. Non-English speaker
  • 6. Claustrophobic
  • 1. MRI incompatible
  • 2. Pregnant or nursing
  • 3. Non-English speaker
  • 4. Claustrophobic

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Stanford University,

Anand Veeravagu, MD, PRINCIPAL_INVESTIGATOR, Stanford University Department of Neurosurgery

Study Record Dates

2024-12-31